Display Settings:

Format

Send to:

Choose Destination

    J Clin Psychiatry. 2004;65 Suppl 10:5-10.

    Correlates of suicidal behavior and lithium treatment in bipolar disorder.

    Dunner DL.

    Center for Anxiety and Depression and the Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle 98105-6099, USA. ddunner@u.washington.edu

    Individuals with bipolar and major depressive disorders have considerably higher suicide rates than the general population. However, estimating the risk of suicide is complicated, and there exists a general lack of consensus among researchers regarding whether suicide rates are higher in patients with unipolar, bipolar I, or bipolar II depressive disorders. Isolating the specific factors that contribute to the high risk of suicide in patients with affective disorders can be challenging as well; substance and alcohol abuse, family history of suicide, differences in allele distributions, comorbid anxiety, depression recurrence, seasonal effects, rapid cycling, and a history of hospitalizations for depression all appear to contribute to the likelihood that these patients will engage in suicidal behavior. Research does tend to agree that lithium is efficacious in decreasing suicidal behavior in patients with affective disorders.

    PMID: 15242326 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Patient drug information

    • Lithium (Eskalith CR®, Eskalith®, Lithobid®)

      Lithium is used to treat and prevent episodes of mania (frenzied, abnormally excited mood) in people with bipolar disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of mania, and ...